These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11757696)

  • 1. Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.
    Press OW
    J Clin Oncol; 2008 Nov; 26(32):5147-50. PubMed ID: 18854559
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunotherapy in mantle cell lymphoma.
    Skarbnik AP; Smith MR
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):201-10. PubMed ID: 22687456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab.
    Sud R; Friedberg JW
    Haematologica; 2008 Dec; 93(12):1776-80. PubMed ID: 19050068
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential effect of statins on rituximab immunotherapy.
    Cragg MS
    PLoS Med; 2008 Mar; 5(3):e77. PubMed ID: 18366253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET.
    Kim JS
    Nucl Med Mol Imaging; 2016 Jun; 50(2):104-11. PubMed ID: 27275358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy-based conditioning regimens for stem cell transplantation.
    Zhang MM; Gopal AK
    Semin Hematol; 2008 Apr; 45(2):118-25. PubMed ID: 18381107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy with 131I-rituximab: what we know and what we don't know.
    Juweid ME
    Cancer Biother Radiopharm; 2003 Aug; 18(4):489-95. PubMed ID: 14503943
    [No Abstract]   [Full Text] [Related]  

  • 8. High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 rituximab.
    Becker W; Behr T
    Ann Hematol; 2001; 80 Suppl 3():B130-1. PubMed ID: 11757696
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloablative anti-CD20 radioimmunotherapy +/- high-dose chemotherapy followed by autologous stem cell support for relapsed/refractory B-cell lymphoma results in excellent long-term survival.
    Wagner JY; Schwarz K; Schreiber S; Schmidt B; Wester HJ; Schwaiger M; Peschel C; von Schilling C; Scheidhauer K; Keller U
    Oncotarget; 2013 Jun; 4(6):899-910. PubMed ID: 23765188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.
    Gopal AK; Gooley TA; Rajendran JG; Pagel JM; Fisher DR; Maloney DG; Appelbaum FR; Cassaday RD; Shields A; Press OW
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):770-5. PubMed ID: 24530971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma.
    Leahy MF; Seymour JF; Hicks RJ; Turner JH
    J Clin Oncol; 2006 Sep; 24(27):4418-25. PubMed ID: 16940276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.
    Hohloch K; Sahlmann CO; Lakhani VJ; Wulf G; Glass B; Hasenkamp J; Meller J; Riggert J; Trümper L; Griesinger F
    Ann Hematol; 2011 Nov; 90(11):1307-15. PubMed ID: 21360108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioimmunotherapy for B-cell lymphoma].
    Tobinai K
    Rinsho Ketsueki; 2006 Jun; 47(6):463-70. PubMed ID: 16862974
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.